Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading update

6 Apr 2022 07:00

RNS Number : 3775H
FD Technologies PLC
06 April 2022
 

 

 

6 April 2022

FD Technologies plc

("FD Technologies" or the "Group")

 

Trading update

 

Delivering on accelerated growth strategy

FD Technologies (AIM: FDP.L, Euronext Growth: FDP.I) today provides a trading update for the financial year ending 28 February 2022 in advance of full year results expected to be announced on 10 May 2022.

The Group expects to achieve its revenue and adjusted EBITDA guidance for the year. Delivery of the accelerated growth strategy announced in May 2021 remains on track, enabling KX to achieve its target of 25% growth in exit Annual Recurring Revenue, driven by increasing take-up of the KX Insights platform. Combined with the recent announcement of our strategic partnership with Microsoft means we have entered the new financial year in a position to build on this momentum.

Seamus Keating, CEO of FD Technologies, commented: "I am pleased with our financial performance and the execution of our accelerated growth strategy in what was a year of transformation for the Group. I'm excited by the opportunities across our business as we win new customers and continue to develop our offering to drive value, performance and returns."

Enquiries

For further information please contact:

 

FD Technologies plc

Seamus Keating, Chief Executive Officer

Ryan Preston, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0) 28 3025 2242

www.fdtechnologies.com

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Virginia Bull

+44 (0) 20 7597 5970

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

+353 1 667 0420

J.P. Morgan Cazenove (Broker)

James A. Kelly

Mose Adigun

+44 (0) 20 7742 4000

 

FTI Consulting (PR Adviser)

+44 (0) 20 3727 1000

Matt Dixon

Dwight Burden

Elena Kalinskaya

 

About FD Technologies

FD Technologies is a group of data-driven businesses that unlock the value of insight, hindsight and foresight to drive organisations forward. The Group comprises KX, the leading technology for real-time continuous intelligence; First Derivative, which provides technology-led services in capital markets; and MRP, the only enterprise-class, predictive Accounts Based Marketing solution. FD Technologies operates from 15 offices across Europe, North America and Asia Pacific, and employs more than 3,000 people worldwide.

For further information, please visit www.fdtechnologies.com and www.kx.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSEFIIEESEIL
Date   Source Headline
6th Jun 20177:00 amRNSEnterprise Securities Market Notice
2nd Jun 20179:56 amRNSAnnual Report 2016/17 and AGM Notice
30th May 20175:13 pmRNSDirector/PDMR Shareholding
30th May 20175:12 pmRNSDirector/PDMR Shareholding
30th May 20172:06 pmRNSIssue of Equity from exercise of Share Options
16th May 20177:00 amRNSFinal Results
15th May 20175:09 pmRNSAppointment and Directorate Change
24th Apr 20177:00 amRNSTrading Update and Notice of Results
3rd Apr 201710:28 amRNSTotal Voting Rights
20th Mar 20177:00 amRNSEnterprise Securities Market Notice
14th Mar 20174:39 pmRNSIssue of Equity
14th Mar 20177:00 amRNSCollaboration Agreement with Airbus
2nd Mar 20177:00 amRNSContract Win
28th Feb 201710:09 amRNSTotal Voting Rights
7th Feb 20177:00 amRNSEnterprise Securities Market Notice
1st Feb 20173:54 pmRNSIssue of Equity
30th Dec 201610:57 amRNSTotal Voting Rights
23rd Dec 20167:00 amRNSEnterprise Securities Market Notice
19th Dec 20164:06 pmRNSIssue of Equity
7th Dec 20161:26 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSEnterprise Securities Market Notice
1st Dec 20164:52 pmRNSIssue of Equity from exercise of Share Options
30th Nov 201612:21 pmRNSTotal Voting Rights
8th Nov 20167:00 amRNSEntry into Retail Analytics market
8th Nov 20167:00 amRNSEnterprise Securities Market Notice
3rd Nov 20164:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:20 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:19 pmRNSDirector/PDMR Shareholding
1st Nov 20166:13 pmRNSIssue of Equity
1st Nov 20167:00 amRNSHalf Yearly Report
19th Oct 20167:00 amRNSNotice of Interim Results
30th Sep 20169:53 amRNSTotal Voting Rights
14th Sep 20167:00 amRNSEnterprise Securities Market Notice
7th Sep 20162:15 pmRNSIssue of Equity from exercise of Share Options
29th Jul 20161:29 pmRNSTotal Voting Rights
20th Jul 20164:59 pmRNSDirector Shareholding - AMENDMENT
19th Jul 20165:03 pmRNSDirector Shareholding
12th Jul 20167:00 amRNSDirector/PDMR Shareholding
30th Jun 20168:05 amRNSTotal Voting Rights
23rd Jun 20162:06 pmRNSResult of AGM
15th Jun 20167:00 amRNSDirector/PDMR Shareholding
6th Jun 201612:00 pmRNSIssue of Equity from exercise of Share Options
3rd Jun 20163:45 pmRNSAnnual Report 2015/16 and AGM Notice
19th May 20165:11 pmRNSHolding(s) in Company
17th May 20167:00 amRNSFinal Results
13th May 20164:38 pmRNSDirectorate Change
27th Apr 20167:00 amRNSStrategic Partnership with Thomson Reuters
26th Apr 20167:00 amRNSNotice of Results
4th Apr 20167:00 amRNSTrading Update
31st Mar 20164:44 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.